Nagendra Chaturvedi

Assistant Professor

University of Nebraska Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nagendra Chaturvedi is an Assistant Professor at the University of Nebraska Medical Center in the United States. His research focuses on pediatric cancers, particularly the roles of immune checkpoints and signaling pathways in neuroblastoma and medulloblastoma. Recent publications highlight the targeting of specific proteins for therapeutic intervention and the exploration of biomarkers for diagnostic and treatment prediction in pediatric tumors.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Sutapa Ray

University of Nebraska Medical Center

UNITED STATES

View details

Sidharth Mahapatra

Assistant Professor

Creighton University

UNITED STATES

View details

Philip Prathipati

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nagendra Chaturvedi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma

STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo

EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis

PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.

Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.

Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy

A novel combination approach targeting an enhanced protein synthesis pathway in MYC-driven (Group 3) medulloblastoma

Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma.

Collaborators (3)

Sutapa Ray

Sidharth Mahapatra

Philip Prathipati

Make your next move.